Urinary cotinine levels of electronic cigarette (e-cigarette) users

References

• Adkison SE, O’Connor RJ, Bansal-Travers M, et al. (2013). Electronic nicotine delivery systems: ınternational tobacco control four-country survey. Am J Prev Med 44:207–15
   PubMed Web of Science ®Google Scholar
• Benowitz NL. (1996). Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18:188–204
   PubMed Web of Science ®Google Scholar
• Bullen C, McRobbie H, Thornley S, et al. (2010). Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control 19:98–103
   PubMed Web of Science ®Google Scholar
• Brajenović N, Karačonji IB, Bulog A. (2015). Evaluation of urinary btex, nicotine, and cotinine as biomarkers of airborne pollutants in nonsmokers and smokers. J Toxicol Environ Health A 78:1133–6
   PubMed Web of Science ®Google Scholar
• Camenga DR, Delmerico J, Kong G, et al. (2014). Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav 39:338–40
   PubMed Web of Science ®Google Scholar
• Caponnetto P, Campagna D, Cibella F, et al. (2013). Efficiency and safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 8:e66317
   PubMed Web of Science ®Google Scholar
• Cheah NP, Chong NWL, Tan J, et al. (2014). Electronic nicotine delivery systems: regulatory and safety challenges: Singapore perspective. Tob Control 23:115–25
   Web of Science ®Google Scholar
• Curvall M, Vala EK, Enzell CR, et al. (1990). Simulation and evaluation of nicotine intake during passive smoking: cotinine measurements in body fluids of nonsmokers given intravenous infusions of nicotine. Clin Pharmacol Ther 47:42–9
   PubMed Web of Science ®Google Scholar
• Cok I, Ozturk R. (2000). Urinary cotinine levels of smokeless tobacco (Maraş powder) users. Hum Exp Toxicol 19:650–5
   PubMed Web of Science ®Google Scholar
• Dawkins L, Corcoran O. (2014). Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology 231:401–7
   PubMed Web of Science ®Google Scholar
• Eissenberg T. (2010). Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control 19:87–8
   PubMed Web of Science ®Google Scholar
• Etter JF, Bullen C. (2011a). Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 106:2017–28
   PubMed Web of Science ®Google Scholar
• Etter JF, Bullen C. (2011b). Saliva cotinine levels in users of electronic cigarettes. Eur Respir J 38:1219–20
   PubMed Web of Science ®Google Scholar
• Etter JF. (2014). Levels of saliva cotinine in electronic cigarette users. Addiction 109:825–9
   PubMed Web of Science ®Google Scholar
• FDA. (2009). U.S. Food and Drug Administration. Family Smoking Prevention and Tobacco Control Act. Available from: http://www.fda.gov/TobaccoProducts/Labeling/RulesRegulationsGuidance/ucm246129.htm [last accessed 9 Jan 2016]
   Google Scholar
• FDA. (2016). U.S. Food and Drug Administration. Deeming – Extending Authorities to Additional Tobacco Products. Available from: http://www.fda.gov/TobaccoProducts/Labeling/RulesRegulationsGuidance/ucm388395.htm [last accessed 9 Jan 2016]
   Google Scholar
• Fischer S, Spiegelhalder B, Preussmann R. (1991). Tobacco-specific nitrosamines in commercial cigarettes: possibilities for reducing exposure. IARC Sci Publ 105:489–92
   PubMedGoogle Scholar
• Flouris AD, Chorti MS, Poulianiti KP, et al. (2013). Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 25:91–101
   PubMed Web of Science ®Google Scholar
• Goniewicz ML, Kuma T, Gawron M, et al. (2013). Nicotine levels in electronic cigarettes. Nicotine Tob Res 15:158–66
   PubMed Web of Science ®Google Scholar
• Haufroid V, Lison D. (1998). Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int Arch Occup Environ Health 71:162–8
   PubMed Web of Science ®Google Scholar
• Hammond K. (2004). Global patterns of nicotine and tobacco consuption. In: Henningfield J, London E, Pogun S, eds. Nicotine psychopharmacology. München: Springer, 3–28
   Google Scholar
• Lutsgarten JA, Wenk ER. (1972). Simple, rapid, kinetic method for serum creatinine measurement. Clin Chem 18:1419–22
   PubMed Web of Science ®Google Scholar
• Man CN, Gam LH, Ismail S, et al. (2006). Simple, rapid and sensitive assay method for simultaneous quantification of urinary nicotine and cotinine using gas chromatography–mass spectrometry. – spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 844:322–7
   PubMed Web of Science ®Google Scholar
• Massadeh AM, Gharaibeh AA, Omari KW. (2009). A single-step extraction method for the determination of nicotine and cotinine in Jordanian smokers’ blood and urine samples by RP-HPLC and GC–MS. J Chromatogr Sci 47:170–7
   PubMed Web of Science ®Google Scholar
• Miller SN, Cocores JA. (1993). Nicotine dependence: diagnosis, chemistry, and pharmacologic treatments. Pediatr Rev 14:275–9
   PubMedGoogle Scholar
• Pagano T, Bida MR, Robinson RJ. (2015). Laboratory activity for the determination of nicotine in electronic cigarette liquids using gas chromatography–mass spectrometry. J Lab Chem Educ 3:37–43
   PubMedGoogle Scholar
• Vansickel AR, Cobb CO, Weaver MF, et al. (2010). A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 19:1945–53
   PubMed Web of Science ®Google Scholar
• Vansickel AR, Eissenberg T. (2013). Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res 15:267–70
   PubMed Web of Science ®Google Scholar
• Vansickel AR, Weaver MF, Eissenberg T. (2012). Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction 107:1493–500
   PubMed Web of Science ®Google Scholar
• Vickerman KA, Carpenter KM, Altman T, et al. (2013). Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res 15:1787–91
   PubMed Web of Science ®Google Scholar
• Westenberger BJ. (2009). Evaluation of e-cigarettes. St Louis, MO: Department of Health and Human Services Food and Drug Administration. Available from: http://www.fda.gov/downloads/Drugs/ScienceResearch/UCM173250.pdf. [last accessed 8 Nov 2015]
   Google Scholar
• Zhu SH, Sun JY, Bonnevie E, et al. (2014). Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 23:iii3–9
   PubMed Web of Science ®Google Scholar